tradingkey.logo
tradingkey.logo
Search

Personalis Announces New Data From Neoadjuvant Lung Cancer Trial

ReutersSep 3, 2025 9:46 PM
facebooktwitterlinkedin

- Personalis Inc PSNL.O:

  • PERSONALIS ANNOUNCES NEW DATA FROM A LANDMARK NEOADJUVANT LUNG CANCER TRIAL SHOWING SUPERIORITY OF ULTRA-SENSITIVE, TUMOR-INFORMED MRD TESTING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI